Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes

Sasha Smith,Pasha Normahani,Tristan Lane,David Hohenschurz-Schmidt,Nick Oliver,Alun Huw Davies

DOI: https://doi.org/10.3390/life12071074

2022-07-20

Life

Abstract:Distal symmetrical polyneuropathy (DSPN) is a serious complication of diabetes associated with significant disability and mortality. Although more than 50% of people with diabetes develop DSPN, its pathogenesis is still relatively unknown. This lack of understanding has limited the development of novel disease-modifying therapies and left the reasons for failed therapies uncertain, which is critical given that current management strategies often fail to achieve long-term efficacy. In this article, the pathogenesis of DSPN is reviewed, covering pathogenic changes in the peripheral nervous system, microvasculature and central nervous system (CNS). Furthermore, the successes and limitations of current therapies are discussed, and potential therapeutic targets are proposed. Recent findings on its pathogenesis have called the definition of DSPN into question and transformed the disease model, paving the way for new research prospects.